VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,189,000 | -16.0% | 761,205 | 0.0% | 0.16% | -21.5% |
| Q1 2022 | $3,798,000 | -25.7% | 761,205 | 0.0% | 0.20% | -17.4% |
| Q4 2021 | $5,115,000 | +22.6% | 761,205 | 0.0% | 0.24% | +12.0% |
| Q3 2021 | $4,171,000 | -16.2% | 761,205 | 0.0% | 0.22% | -2.3% |
| Q2 2021 | $4,978,000 | -29.0% | 761,205 | -9.2% | 0.22% | -23.5% |
| Q1 2021 | $7,009,000 | -61.6% | 838,360 | -67.9% | 0.29% | -63.1% |
| Q4 2020 | $18,261,000 | +62.5% | 2,608,755 | +44.9% | 0.78% | +40.3% |
| Q3 2020 | $11,237,000 | +224.1% | 1,800,747 | +143.1% | 0.56% | +149.1% |
| Q2 2020 | $3,467,000 | +13.6% | 740,740 | 0.0% | 0.22% | +9.8% |
| Q1 2020 | $3,052,000 | -28.3% | 740,740 | 0.0% | 0.20% | -25.5% |
| Q4 2019 | $4,259,000 | +25.8% | 740,740 | 0.0% | 0.27% | -52.8% |
| Q3 2019 | $3,385,000 | -10.4% | 740,740 | 0.0% | 0.58% | +9.6% |
| Q2 2019 | $3,778,000 | -21.5% | 740,740 | 0.0% | 0.53% | -25.7% |
| Q1 2019 | $4,815,000 | -32.6% | 740,740 | 0.0% | 0.71% | -29.2% |
| Q4 2018 | $7,148,000 | -22.9% | 740,740 | 0.0% | 1.01% | +36.7% |
| Q3 2018 | $9,267,000 | -8.4% | 740,740 | 0.0% | 0.74% | -27.6% |
| Q2 2018 | $10,119,000 | -31.7% | 740,740 | 0.0% | 1.02% | -45.3% |
| Q1 2018 | $14,815,000 | +68.5% | 740,740 | 0.0% | 1.86% | +50.7% |
| Q4 2017 | $8,793,000 | -22.7% | 740,740 | 0.0% | 1.23% | -16.7% |
| Q3 2017 | $11,370,000 | +31.6% | 740,740 | 0.0% | 1.48% | +43.3% |
| Q2 2017 | $8,637,000 | – | 740,740 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,332,485 | $34,817,833 | 22.99% |
| Abingworth LLP | 2,457,500 | $64,214,475 | 20.92% |
| Fairmount Funds Management LLC | 2,875,526 | $75,137,494 | 11.92% |
| Octagon Capital Advisors LP | 2,468,000 | $64,488,840 | 10.04% |
| NEA Management Company, LLC | 5,584,753 | $145,929,596 | 8.20% |
| Knoll Capital Management, LLC | 95,391 | $2,492,567 | 5.62% |
| Frazier Life Sciences Management, L.P. | 2,815,720 | $73,574,764 | 4.57% |
| Resolute Capital Asset Partners LLC | 185,992 | $4,860 | 4.34% |
| Caligan Partners LP | 183,064 | $4,783,462 | 3.98% |
| Samsara BioCapital, LLC | 695,001 | $18,160,376 | 3.91% |